You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
哈藥股份(600664.SH)一季度虧損擴至1.87億元
格隆匯 04-27 16:15

格隆匯4月27日丨哈藥股份(600664.SH)發佈2020年第一季度報告,實現營業收入25.11億元,同比減少6.11%;歸屬於上市公司股東的淨虧損1.87億元,去年同期則為淨虧損1.45億元;歸屬於上市公司股東的扣除非經常性損益的淨虧損2.03億元,去年同期則為淨虧損1.63億元;基本每股虧損0.07元。

疫情期間,零售端各類終端門店營業週期縮短、營業時間減少、與疫情相關的治療領域藥品限售或禁售、終端客單量減少,受前述影響,公司高毛利品種銷售收入有所下降,OTC整體業務營業收入也較去年同期有所下降;各類醫療終端醫療資源集中救助新冠疫情,醫療端非抗疫科室接診量下降,整體醫療端常規業務收入大幅減少,受前述影響,公司處方藥業務營業收入較去年同期有所下降;同時,在帶量採購、醫保控費、國談品種降低藥價等系列的政策影響下,藥品盈利空間收窄,公司醫藥批發業務一季度毛利額減少,使公司淨利潤下降。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account